CN Patent

CN106854174A — 一种4位取代哌啶衍生物的制备方法

Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2017-06-16 · 9y expired

What this patent protects

本发明公开了一种4位取代哌啶化合物4-((2-(氨基甲基)-4-溴苯氧基)甲基)哌啶-1-甲酸叔丁酯的制备方法，以5-溴-2-羟基苯甲醛为起始原料，经过肟化、消除、醚化、催化加氢反应得到目标产物，该化合物是重要的医药中间体。

USPTO Abstract

本发明公开了一种4位取代哌啶化合物4-((2-(氨基甲基)-4-溴苯氧基)甲基)哌啶-1-甲酸叔丁酯的制备方法，以5-溴-2-羟基苯甲醛为起始原料，经过肟化、消除、醚化、催化加氢反应得到目标产物，该化合物是重要的医药中间体。

Drugs covered by this patent

Patent Metadata

Patent number
CN106854174A
Jurisdiction
CN
Classification
—
Expires
2017-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Huateng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.